Penrose Hospital is a 364-bed hospital hospital located in Colorado Springs, Colorado and owned by Penrose-Saint Francis Health Services. The campus includes Penrose Hospital, the Penrose Cancer Center, the E Tower building, the Penrose Pavillion, and John Zay House.

There are 364 beds in Penrose Hospital - Emergency Medicine.

During the past decade, Penrose Hospital - Emergency Medicine conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Penrose Hospital - Emergency Medicine" are "COVID-19" (3 trials). Many other conditions were trialed in "Penrose Hospital - Emergency Medicine" in a lesser frequency.

Most popular intervention types in "Penrose Hospital - Emergency Medicine" are "Drug" (3 trials), "Other" (3 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Remdesivir" (3 trials), "Danicopan" (1 trials), "Lenzilumab" (1 trials) and "Risankizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Penrose Hospital - Emergency Medicine" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Penrose Hospital - Emergency Medicine". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Penrose Hospital - Emergency Medicine, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Penrose Hospital - Emergency Medicine, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".